257 related articles for article (PubMed ID: 18278426)
1. Conformational changes and development of proteinase K resistance in surface-immobilized PrP.
Leclerc E; Vetter S
Arch Virol; 2008; 153(4):683-91. PubMed ID: 18278426
[TBL] [Abstract][Full Text] [Related]
2. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
3. Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion.
Pan T; Li R; Kang SC; Wong BS; Wisniewski T; Sy MS
J Neurochem; 2004 Sep; 90(5):1205-17. PubMed ID: 15312175
[TBL] [Abstract][Full Text] [Related]
4. Assembly of natural and recombinant prion protein into fibrils.
Leffers KW; Wille H; Stöhr J; Junger E; Prusiner SB; Riesner D
Biol Chem; 2005 Jun; 386(6):569-80. PubMed ID: 16006244
[TBL] [Abstract][Full Text] [Related]
5. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
Leliveld SR; Stitz L; Korth C
Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
[TBL] [Abstract][Full Text] [Related]
6. Lipid interaction converts prion protein to a PrPSc-like proteinase K-resistant conformation under physiological conditions.
Wang F; Yang F; Hu Y; Wang X; Wang X; Jin C; Ma J
Biochemistry; 2007 Jun; 46(23):7045-53. PubMed ID: 17503780
[TBL] [Abstract][Full Text] [Related]
7. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
[TBL] [Abstract][Full Text] [Related]
8. Antibody binding defines a structure for an epitope that participates in the PrPC-->PrPSc conformational change.
Kanyo ZF; Pan KM; Williamson RA; Burton DR; Prusiner SB; Fletterick RJ; Cohen FE
J Mol Biol; 1999 Nov; 293(4):855-63. PubMed ID: 10543972
[TBL] [Abstract][Full Text] [Related]
9. Complement protein C1q recognizes a conformationally modified form of the prion protein.
Blanquet-Grossard F; Thielens NM; Vendrely C; Jamin M; Arlaud GJ
Biochemistry; 2005 Mar; 44(11):4349-56. PubMed ID: 15766264
[TBL] [Abstract][Full Text] [Related]
10. Epitope mapping of the Syrian hamster prion protein utilizing chimeric and mutant genes in a vaccinia virus expression system.
Rogers M; Serban D; Gyuris T; Scott M; Torchia T; Prusiner SB
J Immunol; 1991 Nov; 147(10):3568-74. PubMed ID: 1719082
[TBL] [Abstract][Full Text] [Related]
11. Preventing misfolding of the prion protein by trimethylamine N-oxide.
Bennion BJ; DeMarco ML; Daggett V
Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
[TBL] [Abstract][Full Text] [Related]
12. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
Lührs T; Zahn R; Wüthrich K
J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
[TBL] [Abstract][Full Text] [Related]
13. Screening a library of potential prion therapeutics against cellular prion proteins and insights into their mode of biological activities by surface plasmon resonance.
Touil F; Pratt S; Mutter R; Chen B
J Pharm Biomed Anal; 2006 Mar; 40(4):822-32. PubMed ID: 16242887
[TBL] [Abstract][Full Text] [Related]
14. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
[TBL] [Abstract][Full Text] [Related]
15. Partial unfolding and refolding of scrapie-associated prion protein: evidence for a critical 16-kDa C-terminal domain.
Kocisko DA; Lansbury PT; Caughey B
Biochemistry; 1996 Oct; 35(41):13434-42. PubMed ID: 8873612
[TBL] [Abstract][Full Text] [Related]
16. A rapid method for detection of PrP by surface plasmon resonance (SPR).
Jiayu W; Xiong W; Jiping L; Wensen L; Ming X; Linna L; Jing X; Haiying W; Hongwei G
Arch Virol; 2009; 154(12):1901-8. PubMed ID: 19862471
[TBL] [Abstract][Full Text] [Related]
17. Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay.
Thackray AM; Hopkins L; Bujdoso R
Biochem J; 2007 Jan; 401(2):475-83. PubMed ID: 17018021
[TBL] [Abstract][Full Text] [Related]
18. Methionine oxidation interferes with conversion of the prion protein into the fibrillar proteinase K-resistant conformation.
Breydo L; Bocharova OV; Makarava N; Salnikov VV; Anderson M; Baskakov IV
Biochemistry; 2005 Nov; 44(47):15534-43. PubMed ID: 16300402
[TBL] [Abstract][Full Text] [Related]
19. Structural insights into the interaction between prion protein and nucleic acid.
Lima LM; Cordeiro Y; Tinoco LW; Marques AF; Oliveira CL; Sampath S; Kodali R; Choi G; Foguel D; Torriani I; Caughey B; Silva JL
Biochemistry; 2006 Aug; 45(30):9180-7. PubMed ID: 16866364
[TBL] [Abstract][Full Text] [Related]
20. Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro.
Tagliavini F; Forloni G; Colombo L; Rossi G; Girola L; Canciani B; Angeretti N; Giampaolo L; Peressini E; Awan T; De Gioia L; Ragg E; Bugiani O; Salmona M
J Mol Biol; 2000 Jul; 300(5):1309-22. PubMed ID: 10903871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
